The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125670792 12567079 2 F 201504 20160705 20160718 20160718 EXP FR-SA-2016SA124949 AVENTIS 76.00 YR E M Y 0.00000 20160718 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125670792 12567079 1 PS TAXOTERE DOCETAXEL 1 Intravenous (not otherwise specified) UNKNOWN 20449 /cycle
125670792 12567079 2 SS TAXOTERE DOCETAXEL 1 Intravenous (not otherwise specified) UNKNOWN 20449 /cycle
125670792 12567079 3 SS TAXOTERE DOCETAXEL 1 Intravenous (not otherwise specified) UNKNOWN 20449 /cycle
125670792 12567079 4 SS TAXOTERE DOCETAXEL 1 Intravenous (not otherwise specified) UNKNOWN 20449 /cycle
125670792 12567079 5 SS CARBOPLATIN. CARBOPLATIN 1 Intravenous (not otherwise specified) UNKNOWN 0 /cycle
125670792 12567079 6 SS CARBOPLATIN. CARBOPLATIN 1 Intravenous (not otherwise specified) UNKNOWN 0 /cycle
125670792 12567079 7 SS CARBOPLATIN. CARBOPLATIN 1 Intravenous (not otherwise specified) UNKNOWN 0 /cycle
125670792 12567079 8 SS CARBOPLATIN. CARBOPLATIN 1 Intravenous (not otherwise specified) UNKNOWN 0 /cycle
125670792 12567079 9 SS CARBOPLATIN. CARBOPLATIN 1 Intravenous (not otherwise specified) UNKNOWN 0 /cycle

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125670792 12567079 1 Squamous cell carcinoma of lung
125670792 12567079 2 Squamous cell carcinoma of lung
125670792 12567079 3 Squamous cell carcinoma of lung
125670792 12567079 4 Squamous cell carcinoma of lung
125670792 12567079 5 Squamous cell carcinoma of lung
125670792 12567079 6 Squamous cell carcinoma of lung
125670792 12567079 7 Squamous cell carcinoma of lung
125670792 12567079 8 Squamous cell carcinoma of lung
125670792 12567079 9 Squamous cell carcinoma of lung

Outcome of event

Event ID CASEID OUTC COD
125670792 12567079 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125670792 12567079 Neuropathy peripheral
125670792 12567079 Skin lesion

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125670792 12567079 1 20150115 20150115 0
125670792 12567079 2 20150204 20150204 0
125670792 12567079 3 20150305 20150305 0
125670792 12567079 4 20150326 20150326 0
125670792 12567079 5 20150115 20150115 0
125670792 12567079 6 20150204 20150204 0
125670792 12567079 7 20150305 20150305 0
125670792 12567079 8 20150326 20150326 0
125670792 12567079 9 20150416 20150416 0